Evidence that oral immunoglobulins (KMP01) suppress pro-tumor inflammation in rectal carcinoma: Case report and treatment concept.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of clinical pharmacology and therapeutics"
DOI: 10.5414/cp204326
Abstract: BACKGROUND A female patient aged 49 years with a rectal adenocarcinoma underwent tumor resection and multiple follow-up surgical operations whilst receiving compassionate therapy with polyvalent immunoglobulins derived from bovine colostrum (KMP01), a potential modulator of… read more here.
Keywords: tumor inflammatory; inflammatory response; pro tumor; treatment ... See more keywords